MedTrace Logo

Expiratory Muscle Strength Training (EMST) in Neuromuscular Disorders

NCT04009408 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-04-21

No results posted yet for this study

Summary

The purpose of this study is to investigate the impact of expiratory muscle strength training (EMST) on the swallowing, breathing, oral intake, quality of life and cough function of people with oculopharyngeal muscular dystrophy (OPMD).

Conditions

  • Oculopharyngeal Muscular Dystrophy
  • Muscular Dystrophies
  • Myopathy; Hereditary

Interventions

DEVICE

Expiratory muscle strength therapy (EMST150, Aspire LLC)

Active therapy calibrated to the participant's maximum expiratory pressure

Sponsors & Collaborators

  • Muscular Dystrophy Canada

    collaborator OTHER

  • University of Calgary

    lead OTHER

Principal Investigators

  • Gerald Pfeffer, MD, PhD · University of Calgary

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-31
Primary Completion
2022-12-01
Completion
2022-12-01
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04009408 on ClinicalTrials.gov